Profile picture

Doctor Seung-Jae Joo

Jeju National University Hospital, Jeju (Korea (Republic of))
Membership: FESC Member
Follow
Biography
Seung-Jae Joo, MD, PhD, FESC is a professor of Jeju National University College of Medicine, and a cardiology specialist of Jeju National University Hospital in South Korea. He was the Director of Jeju Regional Center for Cardiocerebrovascular Diseases, the Dean of Jeju National University School of Medicine, and the President of Jeju National University Hospital in South Korea. As a qualified specialist of echocardiographic imaging, cardiovascular intervention, and critical care medicine, his main activities focus on the clinical care and research about patients with coronary artery diseases, heart failure, and hypertension. His basic research interest lies on the integrin system of platelets and vascular smooth muscle cells.
Logo ESC

Contributor content

The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction
Presentation
The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction
Association of beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mid-range left ventricular ejection fraction after acute myocardial infarction
Presentation
Association of beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mid-range left ventricular ejection fraction after acute myocardial infarction
Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction
Presentation
Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction
Association between six-month blood pressure level and 1-year heart failure in hypertensive patients with acute myocardial infarction
Presentation
Association between six-month blood pressure level and 1-year heart failure in hypertensive patients with acute myocardial infarction
Beta-blockers in patients with preserved left ventricular systolic function after acute myocardial infarction did not improve clinical outcomes
Presentation
Beta-blockers in patients with preserved left ventricular systolic function after acute myocardial infarction did not improve clinical outcomes
Anticoagulation in patients with acute myocardial infarction who were presenting with atrial fibrillation improved clinical outcomes
Presentation
Anticoagulation in patients with acute myocardial infarction who were presenting with atrial fibrillation improved clinical outcomes

ESC 365 is supported by